Gadeta Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
31
- Latest Deal Type
-
M&A
- Investors
-
1
Gadeta General Information
Description
Developer of innovative immunotherapies designed to treat cancer. The company's innovative immunotherapies are based on the discoveries regarding the role of yo T cell receptors (TCRs) in the broad recognition of hematological and solid tumor cells and their potential use for the treatment of advanced malignancies, thereby enabling healthcare institutions and cancer patients to eradicate both hematological and solid tumors, lowering the chances of cancer.
Contact Information
Website
www.gadeta.nlCorporate Office
- Yalelaan 62
- 3584 CM Utrecht
- Netherlands
Corporate Office
- Yalelaan 62
- 3584 CM Utrecht
- Netherlands
Gadeta Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 02-Oct-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 19-Jul-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 29-Mar-2016 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jan-2016 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Generating Revenue |
Gadeta Comparisons
Industry
Financing
Details
Gadeta Competitors (97)
One of Gadeta’s 97 competitors is MaveriX Oncology, a Venture Capital-Backed company based in Palo Alto, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MaveriX Oncology | Venture Capital-Backed | Palo Alto, CA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Ayala Pharmaceuticals | Corporation | Wilmington, DE | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands |
Gadeta Patents
Gadeta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024100136-A1 | Novel method for obtaining gamma t-cell (or delta t-cell) receptor chains (or gamma delta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response | Inactive | 08-Nov-2022 | ||
| US-20240043496-A1 | Delta t-cell or gamma receptor chains or parts thereof for treating ovarian cancer | Inactive | 26-Jul-2022 | ||
| WO-2024013401-A1 | Novel method for identifying gamma t-cell (or delta t-cell) receptor chains (or gammadelta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response | Inactive | 15-Jul-2022 | ||
| US-20240075068-A1 | Novel soluble gamma t-cell (or soluble delta t-cell) receptor chains (or soluble gammadelta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response | Pending | 15-Jul-2022 | ||
| WO-2024013402-A1 | Novel soluble gamma t-cell (or soluble delta t-cell) receptor chains (or soluble gammadelta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response | Inactive | 15-Jul-2022 | C07K14/7051 |
Gadeta Signals
Gadeta Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Baxalta Ventures | Corporate Venture Capital | Minority | ||
| Index Ventures | Venture Capital | Minority | ||
| Kite Pharma | Corporation | Minority | ||
| Medicxi Ventures (UK) | Venture Capital | Minority | ||
| Utrecht Holdings | Not-For-Profit Venture Capital | Minority |
Gadeta FAQs
-
When was Gadeta founded?
Gadeta was founded in 2015.
-
Where is Gadeta headquartered?
Gadeta is headquartered in Utrecht, Netherlands.
-
What is the size of Gadeta?
Gadeta has 31 total employees.
-
What industry is Gadeta in?
Gadeta’s primary industry is Biotechnology.
-
Is Gadeta a private or public company?
Gadeta is a Private company.
-
What is Gadeta’s current revenue?
The current revenue for Gadeta is .
-
How much funding has Gadeta raised over time?
Gadeta has raised $7.78M.
-
Who are Gadeta’s investors?
Baxalta Ventures, Index Ventures, Kite Pharma, Medicxi Ventures (UK), and Utrecht Holdings have invested in Gadeta.
-
Who are Gadeta’s competitors?
MaveriX Oncology, Kite Pharma, AnTolRx, Ayala Pharmaceuticals, and Cristal Therapeutics are some of the 97 competitors of Gadeta.
-
When was Gadeta acquired?
Gadeta was acquired on 02-Oct-2023.
-
Who acquired Gadeta?
Gadeta was acquired by Clade Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process